Progressive Multifocal Leukoencephalopathy stories:
Biogen, Elan shares plummet on new Tysabri review
Oct 23rd, 2009 - Reuters
* European regulators to review risk, benefit of Tysabri * Review follows reports of 23 cases of PML worldwide * Shares of Biogen down 5.5 pct; Elan shares fall 20 pct (Updates share prices) BOSTON...
Europe Take Closer Look at Tysabri Dangers
Oct 23rd, 2009 - Wall Street Journal
A European panel has started a review of controversial multiple sclerosis drug Tysabri, sold by Biogen Idec Inc. and Elan Plc, citing a much higher rate of a rare brain infection than previously disclosed. In a statement...
FDA confirms 3 new infections linked to Tysabri
Sep 22nd, 2009 - Boston
NEW YORK—The Food and Drug Administration says it confirmed three new cases of a potentially lethal brain inflammation linked to the multiple sclerosis drug Tysabri.
Progressive Multifocal Leukoencephalopathy videos from YouTube:
58:41Progressive Multifocal Leukoencephalopathy
Dr. Joseph R. Berger, chair of the Department of Neurology at the University of Kentucky, studies neurological disorders such as progressive multifocal leukoencephalopathy. PML, a rare viral disease, can affect those individuals with compromised immune systems ...
9:44PML Progressive Multifocal Leukoencephalopathy
PLEASE HELP NO MATTER HOW SMALL (it is TAX detuctable) This is a personal video of what this disease is about and where to fund it. NORD 55 Kenosia Ave. PO Box 1968 Danbury, CT 06813-1968 All checks should have "for restricted research for PML" written on the memo line ...
2:00Rituxan Linked to PML (Progressive Multifocal Leukoencephalopathy) Brain Infections
The FDA warns of serious viral brain infection (Progressive Multifocal Leukoencephalopathy) in Rituxan patients. Learn more: www.schmidtandclark.com
8:37Tysabri and the risk of PML
Update on Tysabri and PML: Company Releases Details of Cases and Risks According to information released on October 29, 2009 by Biogen Idec, there have been 24 confirmed cases of progressive multifocal leukoencephalopathy (PML ...
